Current diagnostic strategies for dilated cardiomyopathy: a comparison of imaging techniques
- PMID: 30457393
- DOI: 10.1080/14779072.2019.1550719
Current diagnostic strategies for dilated cardiomyopathy: a comparison of imaging techniques
Abstract
Dilated cardiomyopathy (DCM) is generally thought as a final common pathway of several conditions leading to the same clinical phenotype. Multiple imaging modalities play a fundamental role in recognizing the underlying pathological substrate in DCM. Areas covered: Echocardiography represents the first reliable and easily accessible diagnostic tool, allowing the identification of associated cardiac abnormalities, such as valve disease and highlighting features associated with an adverse prognosis. Recent advances in technology such as strain analysis and 3D-echocardiography have improved the diagnostic and prognostic capabilities of this technique. Cardiac magnetic resonance (CMR) is considered the gold standard for an accurate and reproducible assessment of ventricular volumes and ejection fraction. In addition, CMR allows us to perform tissue characterization that, through new sophisticated sequences, could be obtained even without gadolinium. Nuclear images could be useful to identify specific causes of left ventricular dysfunction, such as cardiac sarcoidosis and amyloidosis. Finally, endomyocardial biopsy is generally performed if acute myocarditis is suspected in high-risk patients. Expert commentary: Strengths and limitations are different for every method, but multiparametric evaluation of patients and family members could progressively improve current understanding of the disease. This is fundamental to specifically target therapy, allowing us to improve patients' prognosis.
Keywords: Cardiac magnetic resonance; dilated cardiomyopathy; echocardiography; future perspectives; integrated imaging; prognosis.
Similar articles
-
A Comprehensive Review of Dilated Cardiomyopathy in Pre-clinical Animal Models in Addition to Herbal Treatment Options and Multi-modality Imaging Strategies.Cardiovasc Hematol Disord Drug Targets. 2023;22(4):207-225. doi: 10.2174/1871529X23666230123122808. Cardiovasc Hematol Disord Drug Targets. 2023. PMID: 36734898 Review.
-
[Research Advances of Diagnostic Value of Magnetic Resonance Imaging in Dilated Cardiomyopathy].Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2016 Oct;33(5):1011-5. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2016. PMID: 29714959 Review. Chinese.
-
[Multislice spiral computed tomography of the heart in dilated cardiomyopathy: possibilities in the verification of myocarditis (in comparison with myocardial biopsy) and in the evaluation of prognosis].Ter Arkh. 2017;89(12):15-27. doi: 10.17116/terarkh2017891215-27. Ter Arkh. 2017. PMID: 29411756 Russian.
-
Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI).Eur Heart J Cardiovasc Imaging. 2018 Apr 1;19(4):459-460n. doi: 10.1093/ehjci/jex154. Eur Heart J Cardiovasc Imaging. 2018. PMID: 29029074
-
Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.Circ Cardiovasc Imaging. 2016 Oct;9(10):e004956. doi: 10.1161/CIRCIMAGING.115.004956. Circ Cardiovasc Imaging. 2016. PMID: 27729359
Cited by
-
Current Insights and Novel Cardiovascular Magnetic Resonance-Based Techniques in the Prognosis of Non-Ischemic Dilated Cardiomyopathy.J Clin Med. 2024 Feb 9;13(4):1017. doi: 10.3390/jcm13041017. J Clin Med. 2024. PMID: 38398330 Free PMC article. Review.
-
Identification of patients with nonischemic dilated cardiomyopathy at risk of malignant ventricular arrhythmias: insights from cardiac magnetic resonance feature tracking.BMC Cardiovasc Disord. 2024 Jan 3;24(1):29. doi: 10.1186/s12872-023-03655-4. BMC Cardiovasc Disord. 2024. PMID: 38172720 Free PMC article.
-
Incremental prognostic value of left atrial and biventricular feature tracking in dilated cardiomyopathy: a long-term study.J Cardiovasc Magn Reson. 2023 Dec 7;25(1):76. doi: 10.1186/s12968-023-00967-4. J Cardiovasc Magn Reson. 2023. PMID: 38057892 Free PMC article.
-
The Role of Multimodality Imaging in Pediatric Cardiomyopathies.J Clin Med. 2023 Jul 24;12(14):4866. doi: 10.3390/jcm12144866. J Clin Med. 2023. PMID: 37510983 Free PMC article. Review.
-
Global burden of myocarditis and cardiomyopathy in children and prediction for 2035 based on the global burden of disease study 2019.Front Cardiovasc Med. 2023 May 2;10:1173015. doi: 10.3389/fcvm.2023.1173015. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37200977 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical